Related Experiment Video

Updated: Jul 5, 2026

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

Ureaplasma parvum lipoproteins, including MB antigen, activate NF-{kappa}B through TLR1, TLR2 and TLR6

Takashi Shimizu1, Yutaka Kida1, Koichi Kuwano1

  • 1Division of Microbiology, Department of Infectious Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.

Microbiology (Reading, England)
|May 3, 2008
PubMed

Insights

Ureaplasma parvum lipoproteins activate the immune system by engaging Toll-like receptors (TLRs) 1, 2, and 6. These lipoproteins trigger nuclear factor kappaB (NF-kappaB) and tumor necrosis factor-alpha, potentially contributing to inflammatory diseases.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Ureaplasma species are common in the female reproductive tract and linked to perinatal diseases.
  • The specific ureaplasma components that trigger inflammatory responses remain unidentified.
  • Toll-like receptors (TLRs) are crucial in initiating immune responses to pathogens.

Purpose of the Study:

  • To investigate the role of TLRs in Ureaplasma parvum-induced immune activation.
  • To identify U. parvum components responsible for activating nuclear factor kappaB (NF-kappaB).

Main Methods:

  • Extraction of U. parvum components using Triton X-114 (TX-114) detergent.
  • Assessing NF-kappaB activation via TLR2 signaling.
  • Utilizing dominant-negative (DN) TLR constructs to delineate receptor involvement.
  • Measuring tumor necrosis factor-alpha (TNF-alpha) induction in macrophages.

Main Results:

  • U. parvum TX-114 detergent phase induced NF-kappaB activation through TLR2.
  • Lipoproteins, including MB antigen, UU012, and UU016, were identified as active components.
  • NF-kappaB activation by these lipoproteins required TLR1, TLR2, and TLR6.
  • U. parvum lipoproteins stimulated TNF-alpha production in mouse macrophages.

Conclusions:

  • Ureaplasma parvum lipoproteins activate NF-kappaB via a pathway involving TLR1, TLR2, and TLR6.
  • These lipoproteins can induce pro-inflammatory cytokine TNF-alpha.
  • Findings elucidate a mechanism for U. parvum-mediated inflammation, potentially linking to perinatal diseases.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...